GSK refuses to be bounced into early consumer unit spin-off

LONDON, Feb 3 (Reuters) - GlaxoSmithKline said on Wednesday it would not be pushed into an early spin-off or sale of its consumer health business, despite speculation the unit could be a target for the likes of Reckitt Benckiser or Procter & Gamble.